Scan barcode
![Evaluation of Pharaceutical Dust Exposures at an Outpatient Pharmacy by Srinivas Durgam, Mark Methner, Centers for Disease Control and Preventi](https://558130.bdp32.group/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNVI3WGc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b5d992926f8f84ff1aa589e48bebb3125dc4eaba/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJYW5CbkJqb0dSVlE2RkhKbGMybDZaVjkwYjE5c2FXMXBkRnNIYVFJc0FXa0M5QUU9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--038335c90cf75c275ae4d36968ac417dc4a0a3e3/Evaluation%20of%20Pharaceutical%20Dust%20Exposures%20at%20an%20Outpatient%20Pharmacy.jpg)
40 pages • missing pub info (editions)
ISBN/UID: 9781493567393
Format: Paperback
Language: English
Publisher: Createspace Independent Publishing Platform
Publication date: 30 April 2013
Description
NIOSH's Health Hazard Evaluation Program received a request from an outpatient pharmacy. The employer was concerned about employee exposures to pharmaceutical dust. NIOSH's findings and recommendations are discussed.
Community Reviews
Content Warnings
![Evaluation of Pharaceutical Dust Exposures at an Outpatient Pharmacy by Srinivas Durgam, Mark Methner, Centers for Disease Control and Preventi](https://558130.bdp32.group/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNVI3WGc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b5d992926f8f84ff1aa589e48bebb3125dc4eaba/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJYW5CbkJqb0dSVlE2RkhKbGMybDZaVjkwYjE5c2FXMXBkRnNIYVFJc0FXa0M5QUU9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--038335c90cf75c275ae4d36968ac417dc4a0a3e3/Evaluation%20of%20Pharaceutical%20Dust%20Exposures%20at%20an%20Outpatient%20Pharmacy.jpg)
40 pages • missing pub info (editions)
ISBN/UID: 9781493567393
Format: Paperback
Language: English
Publisher: Createspace Independent Publishing Platform
Publication date: 30 April 2013
Description
NIOSH's Health Hazard Evaluation Program received a request from an outpatient pharmacy. The employer was concerned about employee exposures to pharmaceutical dust. NIOSH's findings and recommendations are discussed.